EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss of $0.62, Revenues Beat

Go back to EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss of $0.62, Revenues Beat
(NASDAQ: EYPT) Delayed: 13.03 +0.53 (4.24%)
Previous Close $12.50    52 Week High
Open $12.67    52 Week Low
Day High $13.05    P/E N/A 
Day Low $12.61    EPS
Volume 1,093,548